Combined chemotherapy and teratogenicity
- 15 August 2005
- journal article
- case report
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 73 (9) , 634-637
Abstract
BACKGROUND: The concomitant occurrence of breast cancer and pregnancy is relatively uncommon. We report the case of a patient with syndactyly, cleft hands, and absence of distal finger phalanges associated with maternal exposure to chemotherapeutic agents during the first trimester of pregnancy. These associations have not been previously described.CASE: The patient was born by normal delivery after 38 weeks of pregnancy. His mother became pregnant while receiving chemotherapy (cyclophosphamide, 5‐fluorouracil, and adriamycin) for breast cancer, and the fetus was exposed to these drugs from conception to the 16th week of pregnancy. At birth, anomalies were observed, including a high‐arched palate, microcephaly, a flat nasal bridge, bilateral syndactyly in the first and second fingers with a hand cleft between the second and third fingers and hypoplasia of the fifth fingers, and dystrophic nail of the fourth finger of the left hand. The patient's growth and development were deficient.CONCLUSIONS: The malformations associated with in utero exposure to these chemotherapeutic agents are highly variable, but growth deficiency and anomalies of the craniofacial region and limbs are the most common. The pattern of malformations in children who were congenitally exposed to chemotherapeutic agents appears to be directly related to the age at and duration of exposure, rather than to the specific drug itself. Effective contraception is essential for the safe use of a potential teratogen in nonpregnant women of reproductive age. Birth Defects Research (Part A), 2005.Keywords
This publication has 9 references indexed in Scilit:
- Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2004
- Cyclophosphamide, methotrexate, and cytarabine embropathy: Is apoptosis the common pathway?Birth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case reportEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2000
- Apparent cyclophosphamide (cytoxan) embryopathy: A distinct phenotype?American Journal of Medical Genetics, 1999
- BREAST CANCER IN PREGNANCY AND LACTATIONSurgical Clinics of North America, 1996
- Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamideTeratogenesis, Carcinogenesis, and Mutagenesis, 1993
- Multimodal Cancer Therapy for Breast Cancer in the First Trimester of PregnancyJAMA, 1984
- Fetal Effects During Cyclophosphamide and Irradiation TherapyAnnals of Internal Medicine, 1971
- Congenital Anomalies Probably Induced by CyclophosphamideJAMA, 1964